Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
10-day Reverse Hybrid vs Triple Therapy Plus Bismuth for H. pylori
NCT04566211Unknown
- Sponsor
- Kaohsiung Veterans General Hospital
- Start
- Jan 2020
- Primary completion
- Sep 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of pantoprazole, amoxicillin, clarithromycin and metronidazole in Helicobacter pylori infection (2 arms), sponsored by Kaohsiung Veterans General Hospital. Primary endpoint: Number of Participants in Which H. Pylori Was Eradicated at 6 weeks. Status: unknown.
02
Drugs
pantoprazoleamoxicillinclarithromycinmetronidazole
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on NCT04566211.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04566211.